Kalaris Therapeutics (KLRS) Market Capitalization (2020 - 2026)
Kalaris Therapeutics (KLRS) posted Market Capitalization of $96.89 million for Q2 2026, up 94.0% from $49.94 million a year earlier but down 27.0% from the prior quarter.
Kalaris Therapeutics (KLRS) Market Capitalization (2020 - 2026) Analysis & Trends
For FY2025, Kalaris Therapeutics' Market Capitalization came in at $128.86 million, up 166.3% from FY2024.
- Annual Market Capitalization shows a five-year compound annual growth rate of -64.8% (FY2020 to FY2025).
- In prior years, Kalaris Therapeutics' Market Capitalization was $48.38 million in FY2024 (-97.3%), $1.79 billion in FY2023 (-80.3%), $9.04 billion in FY2022 (-52.2%) and $18.92 billion in FY2021 (-20.4%).
- Quarterly Market Capitalization has run from a low of $32.55 million in Q1 2025 to a high of $36.41 billion in Q3 2021 over five years.
- On a year-over-year basis, Market Capitalization has increased in each of the last three quarters, with growth averaging 14.8% over the last eight quarters.
- The strongest year-over-year quarter for Market Capitalization in the past five years was Q1 2026, with growth of 307.6%; the weakest was Q1 2025, with a decline of 98.4%.
- According to Business Quant data, Market Capitalization for the three prior quarters was $132.67 million (Q1 2026), $128.86 million (Q4 2025) and $108.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kalaris Therapeutics | 68.80 Mn | 68.80 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.89 Mn |
| Mar 31, 2026 | 132.67 Mn |
| Dec 31, 2025 | 128.86 Mn |
| Sep 30, 2025 | 108.10 Mn |
| Jun 30, 2025 | 49.94 Mn |
| Mar 31, 2025 | 32.55 Mn |
| Dec 31, 2024 | 48.38 Mn |
| Sep 30, 2024 | 2.15 Bn |
| Jun 30, 2024 | 1.92 Bn |
| Mar 31, 2024 | 1.99 Bn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 5.64 Bn |
| Jun 30, 2023 | 7.40 Bn |
| Mar 31, 2023 | 8.47 Bn |
| Dec 31, 2022 | 9.04 Bn |
| Sep 30, 2022 | 16.81 Bn |
| Jun 30, 2022 | 5.81 Bn |
| Mar 31, 2022 | 9.98 Bn |
| Dec 31, 2021 | 18.92 Bn |
| Sep 30, 2021 | 36.41 Bn |
Kalaris Therapeutics Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=KLRS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();